A research team has developed a deep learning–driven computed tomography (CT) imaging pipeline that enables precise, ...

But Apple has finally addressed how the system manages windows with iPadOS 26, in wide release this fall (and in beta now), and so I decided to give the iPad another shot as a computer replacement.

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September ...

Although recognized as a scientific breakthrough at Fermilab in 1993 and in several international, public scientific reviews (see Sections 3, 6.4, 6.5, 6.6.3, and 10), these inventions have never been ...

Pershing Square Holdings gained 17.7% YTD by reshaping its portfolio and backing Amazon, Uber, and HHH. See how its strategy is evolving; read the full letter.

NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today announced ...

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025 ...

New real-world evidence and clinical trial data provide insights into treatment patterns for several serious cardiovascular diseases, including ASCVD, PH, and HFrEFRAHWAY, N.J.--(BUSINESS WIRE)--Merck ...

In addition, to support access to LEQEMBI for certain patients who need help paying for their medicines, Eisai's Patient Assistance Program (PAP ... which can subsequently adversely affect cognitive ...

On 27 February 2025, Faron received a positive opinion on orphan drug designation for bexmarilimab for the treatment of MDS by EMA, and on 3 March 2025, the FDA granted an orphan drug designation for ...

A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) ...